Stavros E Mountantonakis, Elad Anter, Jerry Marschke, Waruiru Mburu, Reece Holbrook, Hae W Lim, Tyler L Taigen
{"title":"Electrophysiology lab efficiency simulation: a comparison between novel dual-energy lattice-tip and conventional contact-force sensing radiofrequency ablation systems.","authors":"Stavros E Mountantonakis, Elad Anter, Jerry Marschke, Waruiru Mburu, Reece Holbrook, Hae W Lim, Tyler L Taigen","doi":"10.25270/jic/25.00094","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Increasing atrial fibrillation (AF) disease-related healthcare burden, coupled with positive evidence on catheter ablation for AF, has led to pressure on hospital procedure efficiency. Medtronic's Sphere-9 system (a novel lattice-tip dual-energy pulsed field and radiofrequency [RF] ablation catheter) demonstrated non-inferiority in effectiveness and superiority in procedural times compared with a contact-force sensing RF catheter (ThermoCool SmartTouch SF [STSF]). This analysis evaluated the impact of procedural efficiencies on electrophysiology (EP) lab utilization.</p><p><strong>Methods: </strong>A discrete event simulation model evaluated EP lab efficiency using procedure times from the SPHERE Per-AF trial for pulmonary vein isolation-only cases and those with additional ablation lesion sets. Lab day ran from 7 am to 7 pm with 1 hour needed to perform an additional non-ablation EP case, and same-day discharge was allowed for cases ending by 5 pm.</p><p><strong>Results: </strong>Analysis included 211 patients in the Sphere-9 arm and 207 in the STSF arm. Procedure times were 100.8 ± 31 minutes for Sphere-9 and 125.9 ± 49 for STSF. Sphere-9 resulted in more than a 10-fold reduction in cumulative overtime hours (41 hours for Sphere-9 vs 424 for STSF). Overtime occurred on 7% of lab days with Sphere-9 and 36% with STSF. Additionally, 73% of Sphere-9 lab days allowed for 1 additional non-ablation EP case compared with 40% of STSF lab days. Finally, 38% of Sphere-9 lab days allowed for same-day discharge for the third case compared with 17% of STSF lab days.</p><p><strong>Conclusions: </strong>In patients with persistent AF, the Sphere-9 system was more efficient and predictable compared with STSF, leading to significant improvements in EP lab efficiency.</p>","PeriodicalId":49261,"journal":{"name":"Journal of Invasive Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Invasive Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25270/jic/25.00094","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Increasing atrial fibrillation (AF) disease-related healthcare burden, coupled with positive evidence on catheter ablation for AF, has led to pressure on hospital procedure efficiency. Medtronic's Sphere-9 system (a novel lattice-tip dual-energy pulsed field and radiofrequency [RF] ablation catheter) demonstrated non-inferiority in effectiveness and superiority in procedural times compared with a contact-force sensing RF catheter (ThermoCool SmartTouch SF [STSF]). This analysis evaluated the impact of procedural efficiencies on electrophysiology (EP) lab utilization.
Methods: A discrete event simulation model evaluated EP lab efficiency using procedure times from the SPHERE Per-AF trial for pulmonary vein isolation-only cases and those with additional ablation lesion sets. Lab day ran from 7 am to 7 pm with 1 hour needed to perform an additional non-ablation EP case, and same-day discharge was allowed for cases ending by 5 pm.
Results: Analysis included 211 patients in the Sphere-9 arm and 207 in the STSF arm. Procedure times were 100.8 ± 31 minutes for Sphere-9 and 125.9 ± 49 for STSF. Sphere-9 resulted in more than a 10-fold reduction in cumulative overtime hours (41 hours for Sphere-9 vs 424 for STSF). Overtime occurred on 7% of lab days with Sphere-9 and 36% with STSF. Additionally, 73% of Sphere-9 lab days allowed for 1 additional non-ablation EP case compared with 40% of STSF lab days. Finally, 38% of Sphere-9 lab days allowed for same-day discharge for the third case compared with 17% of STSF lab days.
Conclusions: In patients with persistent AF, the Sphere-9 system was more efficient and predictable compared with STSF, leading to significant improvements in EP lab efficiency.
目的:房颤(AF)疾病相关医疗负担的增加,加上房颤导管消融治疗的积极证据,导致医院手术效率的压力。美敦力公司的Sphere-9系统(一种新型的点阵尖端双能脉冲场和射频消融导管)与接触式力传感射频导管(ThermoCool SmartTouch SF [STSF])相比,在有效性和操作时间上都具有优势。该分析评估了程序效率对电生理学(EP)实验室利用率的影响。方法:离散事件模拟模型评估EP实验室效率,使用SPHERE Per-AF试验中仅肺静脉隔离病例和附加消融病变组的手术时间。实验时间从早上7点到晚上7点,需要1小时进行额外的非消融EP病例,并且允许在下午5点结束的病例当天出院。结果:Sphere-9组211例,STSF组207例。Sphere-9手术时间为100.8±31分钟,STSF手术时间为125.9±49分钟。Sphere-9使累计加班时间减少了10倍以上(Sphere-9为41小时,而STSF为424小时)。Sphere-9的加班率为7%,STSF的加班率为36%。此外,73%的Sphere-9实验天数允许额外的1例非消融EP病例,而STSF实验天数为40%。最后,38%的Sphere-9实验室日允许第三例患者当天出院,而STSF实验室日的这一比例为17%。结论:在持续性房颤患者中,与STSF相比,Sphere-9系统更有效和可预测,导致EP实验室效率显著提高。
期刊介绍:
The Journal of Invasive Cardiology will consider for publication suitable articles on topics pertaining to the invasive treatment of patients with cardiovascular disease.